CIAM
CRDF icon

Caitong International Asset Management’s Cardiff Oncology CRDF Stock Holding History

Caitong International Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.1K Buy
22,295
+22,025
+8,157% +$45.2K 0.01% 875
2025
Q4 		$759 Buy
+270
New +$627 ﹤0.01% 1407
2025
Q2 		– Sell
-2,282
Closed -$7.17K – 2085
2025
Q1 		$7.17K Buy
2,282
+936
+70% +$3.7K 0.01% 935
2024
Q4 		$5.84K Buy
+1,346
New +$4.21K 0.01% 1024

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Caitong International Asset Management's CRDF Position: Q1 2026 in Review

Caitong International Asset Management increased its Cardiff Oncology (CRDF) stake by 8,157% in Q1 2026, buying an estimated $45.2K and bringing the position to 22,295 shares worth $36.1K. The position accounts for 0.01% of the portfolio, ranked #875.

Caitong International Asset Management first reported a position in CRDF in Q4 2024 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Caitong International Asset Management held 22,295 shares of Cardiff Oncology worth $36.1K as of Q1 2026.
  • Caitong International Asset Management bought 22,025 Cardiff Oncology shares in Q1 2026, an estimated $45.2K.
  • Cardiff Oncology made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #875 holding.
  • Caitong International Asset Management first reported a position in Cardiff Oncology in Q4 2024 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.